RW de Camargo, LR de Novais Júnior… - Pharmacology …, 2022 - Elsevier
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, onset in early childhood and associated with cognitive, social, behavioral, and sensory impairments. The …
A Manduca, V Buzzelli, A Rava, A Feo… - Pharmacological …, 2024 - Elsevier
Abstract Cannabidiol (CBD), a non-psychotomimetic constituent of Cannabis sativa, has been recently approved for epileptic syndromes often associated with Autism spectrum …
V Trojan, L Landa, A Šulcová, J Slíva, R Hřib - Biomolecules, 2023 - mdpi.com
The use of cannabinoids (substances contained specifically in hemp plants) for therapeutic purposes has received increased attention in recent years. Presently, attention is paid to two …
The endocannabinoid system shows promise as a novel target for treating psychiatric conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in …
G Ferrera, E Ricci, A Vignoli, MN Savini, I Viganò… - Epilepsy & Behavior, 2023 - Elsevier
Seizure frequency in treatment-resistant epilepsies seems to be decreased by cannabidiol (CBD), but contrasting data are available on its effect on sleep, behavior, and quality of life …
SH Shrader, N Mellen, J Cai, GN Barnes… - Frontiers in …, 2024 - frontiersin.org
Introduction The prevalence of Autism Spectrum Disorder (ASD) has drastically risen over the last two decades and is currently estimated to affect 1 in 36 children in the US, according …
K Schwaller, Z Krauss, AMH Chen… - The Journal of …, 2023 - meridian.allenpress.com
OBJECTIVE Data evaluating the use of unlicensed cannabidiol (CBD) products for the treatment of symptoms associated with anxiety and neurodevelopmental disorders in …
X Li, M Yennawar, A Wiest, WT O'Brien… - European Journal of …, 2024 - Wiley Online Library
Abstract Cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD) is caused by a loss‐of‐function mutation in CDKL5 gene, encoding a serine–threonine kinase highly …